Amadix
Amadix is a biotechnology company focused on the development and commercialization of diagnostic tools for personalized oncology treatment.
Amadix has raised €5.7M across 3 funding rounds from 2 investors, most recently a Grant round in Jan 2022. Based in Madrid, Spain; active in Healthtech. Data as of 28 Oct 2026.
Madrid, Spainamadix.com ↗
Total raised
€5.7M
€5,700,000
Funding rounds
3
Investors
2
distinct backers
Active since
2013-02
latest 2022-01
Funding by year
EUR raised per yearAmadix — funding by year — interactive chart.
Data table
| Amadix — funding by year | |
|---|---|
| 2013 | €2.0M |
| 2019 | €1.2M |
| 2022 | €2.5M |
Signals
High confidenceRaise-next likelihood9
base rate 45% for Grant
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-19 | Grant | €2.5M | European Innovation Council (EIC) | View deal → |
| 2019-10-01 | Other | €1.2M | The Crowd Angel | View deal → |
| 2013-02-01 | Other | €2.0M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData